findmyKOL
Clinical trialNCT01589419CompletedPhase 1Interventional

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

SponsorAbbVie (prior sponsor, Abbott)Enrollment32Locally Advanced Rectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Site Reference Id/investigator# 67882

    East Melbourne, Australia

United States
  • Site Reference Id/investigator# 99095

    Scottsdale, Arizona, United States

  • Site Reference Id/investigator# 68044

    Chicago, Illinois, United States

  • Site Reference Id/investigator# 112395

    Goshen, Indiana, United States

  • Site Reference Id/investigator# 68045

    Durham, North Carolina, United States

  • Site Reference Id/investigator# 68043

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2012
Primary completion
31 Jan 2015
Completion
31 Jan 2015
Last update posted
20 Nov 2017
Registered enrollment
32
Registry id
NCT01589419
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.